Insulet Launches Omnipod 5 in Five More European Countries - The Stock Could Soon Break Out of the Months-Long Base!
![](https://tradertimes.com/files/2025/01/Shu-diabetes-20250120-2384634517-1140x440.jpg)
Reading Time: 1 minute
The diabetes market is a megamarket and is also growing very steadily. In addition to major players, insulin pump manufacturers, including Insulet, are particularly exciting. The company's main product is the Omnipod pump, a wearable insulin pump. These pumps can be linked with wearable continuous glucose monitoring devices. The new device, the Omnipod 5, for type 1 patients, is now being launched in five more European countries, including Italy, as announced by Insulet on January 13th. "Following the successful market introduction of the Omnipod...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.